Tag: CBT > Cannabis DEA: Page 3

Cannabis Advertising

The Complex Impact of Rescheduling Cannabis on Advertising

The penalties for advertising Schedule I drugs don’t apply to Schedule III drugs, but cannabis businesses could be left in a precarious position.

September 17, 2024

Industry Headlines

MMJ BioPharma Suing DEA Over Cannabis Reform, Medical Research

The biopharmaceutical company filed a lawsuit, citing ‘unjustified’ delays in processing an application for medical research.

September 11, 2024

Banking Bill Cannabis Industry

Trump Signals Support for Federal Cannabis Rescheduling, Banking Reform

The GOP presidential candidate said he will focus on unlocking the ‘medical uses of marijuana to a Schedule 3 drug’ if elected in November.

September 9, 2024

2018 Farm Bill Status

4th Circuit Court Rules THC-O Meets Legal Definition of Hemp, Deviating From DEA

The federal court’s interpretation of the 2018 Farm Bill contradicts the Drug Enforcement Administration’s position that THC-O is illegal.

September 9, 2024

Texas

Allen Police Department, DEA Raid 9 Texas Vape Shops, Destroy Hemp Products

Local authorities accused the shops of selling noncompliant products, sometimes to minors. An attorney said the police and DEA ‘overstepped their authority.’

August 28, 2024

Cannabis Rescheduling

Cannabis Rescheduling No Longer on Fast Track; Hearing Scheduled For December

The DEA will not issue a final rule before the November election now that Administrator Anne Milgram granted an administrative law judge hearing.

August 27, 2024

Interviews & Opinion

Rescheduling Update: How Long Is the Wait? What’s Next?

Government affairs and policy expert David Mangone tells us what we can expect from the DEA as weeks pass following the public comment period, including insights on the DEA’s final review and if a hearing is likely to be granted.

August 8, 2024

Cannabis Rescheduling

Cannabis Rescheduling Nearly ‘Done Deal,’ Story Cannabis CEO Says

Jason Vedadi, the former executive chairman for Harvest Health before its acquisition by Trulieve, talks exclusively with CBT on what he expects from federal rescheduling as the industry awaits the DEA’s final determination.

July 29, 2024

Cannabis Rescheduling

43,000 Comments Filed on Cannabis Rescheduling Proposal as Public Period Closes

The Drug Enforcement Administration will now weigh these comments and potentially hold administrative law hearings before issuing a final rule.

July 23, 2024

Cannabis Rescheduling

9 US Senators Urge VA to Expand Access to Medical Cannabis for America’s Veterans

Sen. Jeff Merkley led the group in a letter to U.S. Secretary of Veterans Affairs Denis McDonough following the DEA’s rescheduling recommendation.

July 19, 2024

Kentucky

Kentucky Governor Urges DEA to Reschedule: ‘The Jury is No Longer Out on Marijuana’

Gov. Andy Beshear wrote a letter to DEA Administrator Anne Milgram expressing his support for reclassifying cannabis to a Schedule III substance.

July 17, 2024

Federal Cannabis Legalization

25 GOP Lawmakers Condemn Cannabis Rescheduling in New Letter

Sen. James Lankford and Rep. Pete Sessions spearheaded the letter sent to Attorney General Merrick Garland, saying rescheduling lacks “adequate science.”

July 12, 2024